<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="mngie" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">mngie</book-part-id>
      <title-group>
        <title>Mitochondrial Neurogastrointestinal Encephalopathy Disease</title>
        <alt-title alt-title-type="alt-title">Synonyms: MNGIE Syndrome, Mitochondrial Neurogastrointestinal Encephalopathy Syndrome, Thymidine Phosphorylase Deficiency</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hirano</surname>
            <given-names>Michio</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>H Houston Merritt Center<break/>Department of Neurology <break/>Columbia University Medical Center<break/>New York, New York</aff>
          <email>mh29@columbia.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>22</day>
          <month>4</month>
          <year>2005</year>
        </date>
        <date date-type="updated">
          <day>14</day>
          <month>1</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="mt-mpan" document-type="chapter">Mitochondrial Membrane Protein-Associated Neurodegeneration</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="mws" document-type="chapter">Mowat-Wilson Syndrome</related-object>
      <abstract id="mngie.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease is characterized by progressive gastrointestinal dysmotility (manifesting as early satiety, nausea, dysphagia, gastroesophageal reflux, postprandial emesis, episodic abdominal pain and/or distention, and diarrhea); cachexia; ptosis/ophthalmoplegia or ophthalmoparesis; leukoencephalopathy; and demyelinating peripheral neuropathy (manifesting as paresthesias (tingling, numbness, and pain) and symmetric and distal weakness more prominently affecting the lower extremities). The order in which manifestations appear is unpredictable. Onset is usually between the first and fifth decades; in about 60% of individuals, symptoms begin before age 20 years.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The clinical diagnosis of MNGIE disease is based on the presence of severe gastrointestinal dysmotility, cachexia, ptosis, external ophthalmoplegia, sensorimotor neuropathy, asymptomatic leukoencephalopathy as observed on brain MRI, and family history consistent with autosomal recessive inheritance. The diagnosis of MNGIE disease can be established in a proband by detection of one of the following: (1) biallelic pathogenic variants in <italic toggle="yes">TYMP</italic> (formerly known as <italic toggle="yes">ECGF1</italic>); (2) markedly reduced levels of thymidine phosphorylase enzyme activity; or (3) elevated plasma concentrations of thymidine and deoxyuridine.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Management is primarily supportive and includes attention to swallowing difficulties and airway protection; dromperidone for nausea and vomiting; gastrostomy, and parenteral feeding for nutritional support; antibiotics for intestinal bacterial overgrowth; amitriptyline, nortriptyline, and gabapentin for neuropathic symptoms; specialized schooling arrangements; and physical and occupational therapy.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Attention to swallowing abnormalities and diverticulosis, respectively, may help prevent aspiration pneumonia and ruptured diverticula.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Drugs that interfere with mitochondrial function should be avoided; medications primarily metabolized in the liver should be used with caution.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>MNGIE disease is inherited in an autosomal recessive manner. The parents of an affected individual are obligate heterozygotes and therefore carry one mutated allele; heterozygotes are asymptomatic. Unless an individual with MNGIE disease has offspring with either an affected individual or a carrier, his/her offspring will be obligate heterozygotes for a pathogenic variant in <italic toggle="yes">TYMP</italic>. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible once the <italic toggle="yes">TYMP</italic> pathogenic variants in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="mngie.Diagnosis">
        <title>Diagnosis</title>
        <sec id="mngie.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>MNGIE (<italic toggle="yes">m</italic>itochondrial <italic toggle="yes">n</italic>euro<italic toggle="yes">g</italic>astro<italic toggle="yes">i</italic>ntestinal <italic toggle="yes">e</italic>ncephalopathy) disease <bold>is</bold>
<bold>suggested</bold> by the presence of the following clinical findings, neuroimaging, and family history [<xref ref-type="bibr" rid="mngie.REF.hirano.1994.721">Hirano et al 1994</xref>, <xref ref-type="bibr" rid="mngie.REF.nishino.1999.689">Nishino et al 1999</xref>, <xref ref-type="bibr" rid="mngie.REF.garone.2011.3326">Garone et al 2011</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Clinical findings</p>
              <list list-type="bullet">
                <list-item>
                  <p>Severe gastrointestinal (GI) dysmotility</p>
                </list-item>
                <list-item>
                  <p>Cachexia</p>
                </list-item>
                <list-item>
                  <p>Ptosis</p>
                </list-item>
                <list-item>
                  <p>External ophthalmoplegia</p>
                </list-item>
                <list-item>
                  <p>Sensorimotor neuropathy (usually mixed axonal and demyelinating)</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Neuroimaging.</bold> Asymptomatic leukoencephalopathy manifest as diffusely abnormal brain white matter (increased FLAIR or T<sub>2</sub>-weighted signal) on brain MRI. Relative sparing of the corpus callosum is reported in some individuals [<xref ref-type="bibr" rid="mngie.REF.vissing.2002.926">Vissing et al 2002</xref>, <xref ref-type="bibr" rid="mngie.REF.hirano.2004.8">Hirano et al 2004</xref>]. (In the absence of leukoencephalopathy, MNGIE disease is very unlikely.)</p>
              <p>Note: Although magnetic resonance spectroscopy (MRS) can show increases in lactate within the white matter, it is not a sensitive diagnostic test.</p>
            </list-item>
            <list-item>
              <p><bold>Family history</bold> consistent with autosomal recessive inheritance</p>
            </list-item>
          </list>
        </sec>
        <sec id="mngie.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of MNGIE disease <bold>is</bold>
<bold>established</bold> in a proband by detection of one of the following: (1) biallelic pathogenic variants in <italic toggle="yes">TYMP</italic> (formerly known as <italic toggle="yes">ECGF1</italic>) (<xref ref-type="table" rid="mngie.T.summary_of_molecular_genetic_tes">Table 1</xref>); (2) markedly reduced levels of thymidine phosphorylase enzyme activity; or (3) elevated plasma concentrations of thymidine and deoxyuridine.</p>
          <p>Molecular genetic testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">TYMP</italic> is performed first, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">TYMP</italic> and other genes of interest (see <xref ref-type="sec" rid="mngie.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, mitochondrial sequencing, and genome sequencing may be considered if single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">TYMP</italic>) fails to confirm a diagnosis in an individual with features of MNGIE disease. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="mngie.T.summary_of_molecular_genetic_tes" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE) Disease</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_mngie.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_mngie.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_mngie.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_mngie.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">TYMP</italic>
                  </td>
                  <td headers="hd_h_mngie.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_mngie.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">100%<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_mngie.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_mngie.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="mngie.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="mngie" object-id="mngie.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="mngie.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="mngie.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="mngie.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="mngie.TF.1.4">
                <label>4. </label>
                <p>Individuals with enzymatically proven MNGIE disease [<xref ref-type="bibr" rid="mngie.REF.nishino.1999.689">Nishino et al 1999</xref>, <xref ref-type="bibr" rid="mngie.REF.nishino.2000.792">Nishino et al 2000</xref>, <xref ref-type="bibr" rid="mngie.REF.garone.2011.3326">Garone et al 2011</xref>]</p>
              </fn>
              <fn id="mngie.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="mngie.TF.1.6">
                <label>6. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Thymidine phosphorylase enzyme (E.C.2.4.2.4) activity</bold> in buffy coat in individuals with MNGIE disease that is less than 8% of the control mean is sufficient to diagnose the disease; however, in late-onset MNGIE disease buffy coat TP activity is less severely diminished (e.g., &#x0003c;18% of the control mean) [<xref ref-type="bibr" rid="mngie.REF.nishino.1999.689">Nishino et al 1999</xref>, <xref ref-type="bibr" rid="mngie.REF.mart_.2004.120">Mart&#x000ed; et al 2004</xref>].</p>
          <p><bold>Plasma concentrations of thymidine and deoxyuridine.</bold> Increase in plasma thymidine concentration greater than 3 &#x000b5;mol/L or increase in plasma deoxyuridine concentration greater than 5 &#x000b5;mol/L is sufficient to make the diagnosis of MNGIE disease [<xref ref-type="bibr" rid="mngie.REF.mart_.2004.120">Mart&#x000ed; et al 2004</xref>].</p>
        </sec>
      </sec>
      <sec id="mngie.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="mngie.Clinical_Description">
          <title>Clinical Description</title>
          <p>MNGIE disease is characterized by the following major manifestations: gastrointestinal dysmotility, cachexia, progressive external ophthalmoplegia with or without ptosis, peripheral neuropathy, and leukoencephalopathy.</p>
          <p>Gestation and delivery are normal. The earliest reported age of onset is five months; onset is usually between the first and fifth decades. In about 60% of individuals, symptoms begin before age 20 years (mean age at onset: 18 years) [<xref ref-type="bibr" rid="mngie.REF.garone.2011.3326">Garone et al 2011</xref>].</p>
          <p>Prior to the onset of symptoms, many individuals with MNGIE disease are healthy, but usually have a long history of subtle fatigability, mild gastrointestinal symptoms, or thin body habitus.</p>
          <p>The order in which manifestations appear is unpredictable; however, in a review of 102 patients, the first symptoms were gastrointestinal (~57%), ptosis/ophthalmoplegia (~19%), peripheral neuropathy (~14%), and myopathy (~5%) [<xref ref-type="bibr" rid="mngie.REF.garone.2011.3326">Garone et al 2011</xref>].</p>
          <p>Late-onset MNGIE disease occurs in individuals harboring pathogenic <italic toggle="yes">TYMP</italic> variants that produce less severe thymidine phosphorylase dysfunction [<xref ref-type="bibr" rid="mngie.REF.mart_.2005.649">Mart&#x000ed; et al 2005</xref>].</p>
          <p><bold>Gastrointestinal dysmotility and cachexia.</bold> Progressive GI dysmotility, caused primarily by enteric myopathy, occurs in virtually all individuals with MNGIE disease at some point during the course of the illness [<xref ref-type="bibr" rid="mngie.REF.giordano.2008.1120">Giordano et al 2008</xref>]. Symptoms usually progress slowly over several decades and can affect any part of the GI tract. Gastric and small bowel hypomotility are the most common. Symptoms include early satiety, nausea, dysphagia, gastroesophageal reflux, postprandial emesis, episodic abdominal pain, episodic abdominal distention, and diarrhea.</p>
          <p>Weight loss and cachexia coincide with the onset of GI symptoms. The average weight loss is about 15 kg [<xref ref-type="bibr" rid="mngie.REF.nishino.2000.792">Nishino et al 2000</xref>]. Affected individuals invariably have a thin body habitus and reduced muscle mass. Despite severe GI dysfunction, serum concentrations of micronutrients, vitamins E and B<sub>12</sub>, and folate are typically normal.</p>
          <p><bold>Histologic findings.</bold> Rectal biopsy can show eosinophilic cytoplasmic inclusions, representing abnormal mitochondria, in the submucosal ganglion cells [<xref ref-type="bibr" rid="mngie.REF.perezatayde.1998.1141">Perez-Atayde et al 1998</xref>].</p>
          <p>Duodenal pathology can demonstrate focal muscle atrophy or absence with increased nerve numbers, serosal granulomas, and focal loss of Auerbach's plexus with fibrosis [<xref ref-type="bibr" rid="mngie.REF.teitelbaum.2002.377">Teitelbaum et al 2002</xref>].</p>
          <p>Mitochondrial DNA depletion, mitochondrial proliferation, and smooth cell atrophy are observed in the external layer of the muscularis propria in the stomach and in the small intestine [<xref ref-type="bibr" rid="mngie.REF.giordano.2006.893">Giordano et al 2006</xref>, <xref ref-type="bibr" rid="mngie.REF.giordano.2008.1120">Giordano et al 2008</xref>].</p>
          <p>Loss of the pacemaker cells that stimulate gut contraction (interstitial cells of Cajal) is also noted in the small bowel [<xref ref-type="bibr" rid="mngie.REF.zimmer.2009.627">Zimmer et al 2009</xref>].</p>
          <p><bold>Eye findings.</bold> Ptosis and ophthalmoplegia (weakness of the extraocular muscles) or ophthalmoparesis (lack of function of the extraocular muscles) are common findings. Because of the absence of symptoms like diplopia, individuals with MNGIE disease are often unaware of the eye movement defect. Instead, the abnormalities are usually first noted by a health care provider.</p>
          <p><bold>Sensorimotor neuropathy.</bold> All individuals with MNGIE disease have peripheral neuropathy. The neuropathy is demyelinating in all cases and about half also have axonal neuropathy. In some, the first symptoms are paresthesias and weakness. Paresthesias occur in a stocking-glove distribution and may be described as tingling, numbness, or even pain. The weakness is usually symmetric and distal. Lower extremities are more prominently affected than upper extremities. Unilateral or bilateral foot drop, as well as clawed hands, may occur. The severity of the neuropathic symptoms often fluctuates during the early stages of the disease.</p>
          <p>The segmental demyelination is hypothesized to be caused by the uneven distribution of mtDNA abnormalities (depletion, single-nucleotide variants, deletions, duplications) along the nerve. Areas with the highest concentration of these pathogenic variants may be predisposed to demyelination.</p>
          <p>Electrodiagnostic features can include decreased motor and sensory nerve conduction velocities, prolonged F-wave latency, and partial conduction block. Myopathic changes are common.</p>
          <p>Histologically, demyelination and remyelination (onion bulb formation) are observed. Loss of large myelinated fibers is common.</p>
          <p><bold>Leukoencephalopathy.</bold> The leukoencephalopathy is usually asymptomatic. Spasticity is not present. Although intellectual disability is described in some individuals, dementia can be a rare late feature of the disease [<xref ref-type="bibr" rid="mngie.REF.carodartal.2007.581">Carod-Artal et al 2007</xref>].</p>
          <p>
            <bold>Other highly variable clinical manifestations</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Active hepatic cirrhosis with increased liver enzymes and macrovesicular steatosis</p>
            </list-item>
            <list-item>
              <p>Anemia</p>
            </list-item>
            <list-item>
              <p>Early-onset sensorineural hearing loss involving either the cochlea or eighth cranial nerve.</p>
            </list-item>
            <list-item>
              <p>Diverticula, which may become infected (diverticulitis) or perforate, causing peritonitis, which may be fatal.</p>
            </list-item>
            <list-item>
              <p>Hypergonadotropic hypogonadism [<xref ref-type="bibr" rid="mngie.REF.kalkan.2012.377">Kalkan et al 2012</xref>] and hypogonadotropic hypogonadism [<xref ref-type="bibr" rid="mngie.REF.carodartal.2007.581">Carod-Artal et al 2007</xref>] have been reported in isolated patients.</p>
            </list-item>
          </list>
          <p><bold>Prognosis.</bold> MNGIE disease is a progressive, degenerative disease with a poor prognosis. In the study of <xref ref-type="bibr" rid="mngie.REF.garone.2011.3326">Garone et al [2011]</xref>, the mean age of death was 35 years (range 15-54 years).</p>
          <p>
            <bold>Other laboratory findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Significantly increased CSF protein (typically 60 - &#x0003e;100 mg/dL; normal: 15 - 45 mg/dL)</p>
            </list-item>
            <list-item>
              <p>Lactic acidemia (increased serum concentration of lactate without a change in the pH) and hyperalaninemia are common. Lactic acidosis (increased serum lactate concentration associated with a decrease in blood pH) is unusual, but is more likely to occur in the presence of renal or hepatic impairment.</p>
            </list-item>
            <list-item>
              <p>Evidence of mitochondrial dysfunction manifest by any of the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Histologic abnormalities of a mitochondrial myopathy including ragged-red fibers (Gomori trichrome) and defects in single or multiple OXPHOS enzyme complexes. The most common defect is in cytochrome <italic toggle="yes">c</italic> oxidase (complex IV).</p>
                  <p>Note: Normal muscle histopathology can be observed [<xref ref-type="bibr" rid="mngie.REF.szigeti.2004.125">Szigeti et al 2004</xref>].</p>
                </list-item>
                <list-item>
                  <p>Acquired mitochondrial DNA (mtDNA) deletions/duplications detected in any tissue by Southern blot analysis and long-range PCR</p>
                </list-item>
                <list-item>
                  <p>Mitochondrial DNA depletion detected by quantitation of mtDNA relative to nuclear DNA</p>
                </list-item>
                <list-item>
                  <p>Site-specific mtDNA single-nucleotide variants detected in blood and tissues</p>
                </list-item>
                <list-item>
                  <p>Other metabolic abnormalities including increased urine concentrations of deoxyuridine and thymidine. These compounds are not detectable in controls or in individuals who are heterozygous for a <italic toggle="yes">TYMP</italic> pathogenic variant [<xref ref-type="bibr" rid="mngie.REF.fairbanks.2002.603">Fairbanks et al 2002</xref>, <xref ref-type="bibr" rid="mngie.REF.spinazzola.2002.4128">Spinazzola et al 2002</xref>, <xref ref-type="bibr" rid="mngie.REF.mart_.2003.14">Mart&#x000ed; et al 2003</xref>, <xref ref-type="bibr" rid="mngie.REF.nishigaki.2003.1913">Nishigaki et al 2003</xref>].</p>
                </list-item>
                <list-item>
                  <p>Post-mortem increases in nucleosides in all tissues [<xref ref-type="bibr" rid="mngie.REF.valentino.2007.3410">Valentino et al 2007</xref>]</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="mngie.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Late-onset disease occurs in individuals harboring <italic toggle="yes">TYMP</italic> pathogenic variants that produce less severe thymidine phosphorylase dysfunction, such as the c.622G&#x0003e;A variant (p.Val208Met), identified in two of four patients [<xref ref-type="bibr" rid="mngie.REF.mart_.2005.649">Mart&#x000ed; et al 2005</xref>, <xref ref-type="bibr" rid="mngie.REF.massa.2009.837">Massa et al 2009</xref>].</p>
        </sec>
        <sec id="mngie.Nomenclature">
          <title>Nomenclature</title>
          <p>MNGIE disease was first described as congenital oculo-skeletal myopathy with abnormal muscle and liver mitochondria. Other names for MNGIE disease include polyneuropathy, ophthalmoplegia, leukoencephalopathy, and intestinal pseudo-obstruction (POLIP); oculogastrointestinal muscular dystrophy (OGIMD); and mitochondrial myopathy with sensorimotor polyneuropathy, ophthalmoplegia, and pseudo-obstruction (MEPOP).</p>
        </sec>
        <sec id="mngie.Prevalence">
          <title>Prevalence</title>
          <p>MNGIE disease is rare. The prevalence is unknown. More than 120 individuals with features consistent with MNGIE disease have been reported since it was first described.</p>
          <p>No ethnic predilection for MNGIE disease has been observed; it occurs in individuals of mixed European, Turkish, Puerto Rican, Ashkenazi Jewish, Iranian Jewish, German American, Asian, Spanish, and African American heritage.</p>
          <p>Parental consanguinity is common, occurring in nearly half the families in some reports [<xref ref-type="bibr" rid="mngie.REF.nishino.1999.689">Nishino et al 1999</xref>, <xref ref-type="bibr" rid="mngie.REF.nishino.2000.792">Nishino et al 2000</xref>].</p>
        </sec>
      </sec>
      <sec id="mngie.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">TYMP</italic>.</p>
      </sec>
      <sec id="mngie.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>MNGIE (<italic toggle="yes">m</italic>itochondrial <italic toggle="yes">n</italic>euro<italic toggle="yes">g</italic>astro<italic toggle="yes">i</italic>ntestinal <italic toggle="yes">e</italic>ncephalopathy) disease has been confused with anorexia nervosa and other classes of GI diseases such as intestinal pseudo-obstruction (e.g., <related-object link-type="booklink" source-id="gene" document-id="actg2-dis" document-type="chapter"><italic toggle="yes">ACTG2</italic>-related disorders</related-object>), inflammatory bowel disease, <related-object link-type="booklink" source-id="gene" document-id="celiac" document-type="chapter">celiac disease</related-object>, and irritable bowel disease. Acute abdominal pain in individuals with MNGIE disease has been misdiagnosed as superior mesenteric artery syndrome.</p>
        <p>Because of the rapid appearance of neuropathic symptoms over several months in some individuals, chronic inflammatory demyelinating polyneuropathy (CIDP) has been misdiagnosed [<xref ref-type="bibr" rid="mngie.REF.bedlack.2004.364">Bedlack et al 2004</xref>, <xref ref-type="bibr" rid="mngie.REF.said.2005.655">Said et al 2005</xref>].</p>
        <p><bold>Oxidative phosphorylation (OXPHOS) diseases.</bold> Because of the cumulative effects on cells of mtDNA depletion and increasing levels of mtDNA deletions and single-nucleotide variants (SNVs) in MNGIE disease, affected individuals present with clinical and metabolic features of oxidative phosphorylation diseases, which are characterized by GI dysmotility, polyneuropathy, and leukoencephalopathy (see <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/phenotypicSeries/PS603041">Mitochondrial DNA depletion syndrome: OMIM Phenotypic Series</ext-link>, to view genes associated with this phenotype in OMIM).</p>
        <p>However, when the diagnostic criteria for MNGIE disease are strictly applied, thymidine phosphorylase activity and molecular genetic testing of <italic toggle="yes">TYMP</italic> are found to be normal in these other disorders [<xref ref-type="bibr" rid="mngie.REF.vissing.2002.926">Vissing et al 2002</xref>, <xref ref-type="bibr" rid="mngie.REF.hirano.2004.8">Hirano et al 2004</xref>].</p>
        <p>
          <bold>Disorders caused by imbalance in the mitochondrial nucleotide pools or by quantitative or qualitative defects in mtDNA</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p>Autosomal dominant progressive external ophthalmoplegia, caused by:</p>
            <list list-type="bullet">
              <list-item>
                <p>Mutation of <italic toggle="yes">SLC25A4</italic> ( previously known as <italic toggle="yes">ANT1)</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609283">OMIM</ext-link>), the gene encoding the heart/skeletal muscle isoform of adenine nucleotide translocator [<xref ref-type="bibr" rid="mngie.REF.kaukonen.2000.782">Kaukonen et al 2000</xref>];</p>
              </list-item>
              <list-item>
                <p>Mutation of <italic toggle="yes">TWNK</italic> (formerly <italic toggle="yes">C10orf2</italic>) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609286">OMIM</ext-link>)<italic toggle="yes">,</italic> the gene encoding twinkle, a mitochondrial DNA helicase required for mtDNA integrity [<xref ref-type="bibr" rid="mngie.REF.spelbrink.2001.223">Spelbrink et al 2001</xref>];</p>
              </list-item>
              <list-item>
                <p>Mutation of <italic toggle="yes">POLG</italic> or <italic toggle="yes">POLG2</italic> (see <related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter"><italic toggle="yes">POLG</italic>-Related Disorders</related-object>), the genes encoding the two subunits of DNA polymerase gamma, which is responsible for mtDNA replication [<xref ref-type="bibr" rid="mngie.REF.van_goethem.2001.211">Van Goethem et al 2001</xref>];</p>
              </list-item>
              <list-item>
                <p>Mutation of <italic toggle="yes">RRM2B</italic>, the gene encoding the small subunit of p53-inducible ribonucleotide reductase (See <related-object link-type="booklink" source-id="gene" document-id="rrm2b-mtddepl" document-type="chapter"><italic toggle="yes">RRM2B</italic>-Related Mitochondrial Disease</related-object>).</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter">Kearns-Sayre syndrome/chronic progressive external ophthalmoplegia</related-object>, caused by sporadic mtDNA deletions/duplications</p>
          </list-item>
          <list-item>
            <p>A larger array of mtDNA diseases caused by single-nucleotide variants (SNVs) (For reviews see <xref ref-type="bibr" rid="mngie.REF.schon.2012.878">Schon et al [2012]</xref> and <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>.)</p>
          </list-item>
          <list-item>
            <p>Mitochondrial myopathy with mtDNA depletion caused by pathogenic variants in <italic toggle="yes">TK2</italic>, the gene encoding thymidine kinase [<xref ref-type="bibr" rid="mngie.REF.saada.2001.342">Saada et al 2001</xref>] (See <related-object link-type="booklink" source-id="gene" document-id="tk2-mtddepl" document-type="chapter"><italic toggle="yes">TK2</italic>-Related Mitochondrial DNA Depletion Syndrome, Myopathic Form</related-object>.)</p>
          </list-item>
          <list-item>
            <p>Mitochondrial hepatopathy and encephalopathy with mtDNA depletion caused by pathogenic variants in <italic toggle="yes">DGUOK</italic>, the gene encoding deoxyguanosine kinase [<xref ref-type="bibr" rid="mngie.REF.mandel.2001.337">Mandel et al 2001</xref>] or in <italic toggle="yes">MPV17</italic>, the gene encoding a mitochondrial inner membrane protein necessary for mtDNA maintenance [<xref ref-type="bibr" rid="mngie.REF.spinazzola.2006.570">Spinazzola et al 2006</xref>] (See <related-object link-type="booklink" source-id="gene" document-id="dguok-mtddepl" document-type="chapter"><italic toggle="yes">DGUOK</italic>-Related Mitochondrial DNA Depletion Syndrome, Hepatocerebral Form</related-object> and <related-object link-type="booklink" source-id="gene" document-id="mpv17-mtdep" document-type="chapter"><italic toggle="yes">MPV17</italic>-related Hepatocerebral Mitochondrial DNA Depletion Syndrome</related-object>.)</p>
          </list-item>
          <list-item>
            <p>Multisystemic diseases with mtDNA depletion caused by mutation of:</p>
            <list list-type="bullet">
              <list-item>
                <p><italic toggle="yes">RRM2B</italic>, the gene encoding the small subunit of p53-inducible ribonucleotide reductase (see <related-object link-type="booklink" source-id="gene" document-id="rrm2b-mtddepl" document-type="chapter"><italic toggle="yes">RRM2B</italic>-Related Mitochondrial Disease</related-object>);</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">SUCLA2</italic>, encoding succinyl-CoA ligase, ADP-forming, beta subunit (see <related-object link-type="booklink" source-id="gene" document-id="sucla2-def" document-type="chapter"><italic toggle="yes">SUCLA2</italic>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Mild Methylmalonic Aciduria</related-object>);</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">SUCLG2</italic>, encoding the succinyl-CoA ligase, GDP-forming, beta subunit;</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">MGME1,</italic> encoding a protein required for mtDNA synthesis [<xref ref-type="bibr" rid="mngie.REF.kornblum.2013.214">Kornblum et al 2013</xref>].</p>
              </list-item>
            </list>
          </list-item>
        </list>
        <p><bold>Leukodystrophy.</bold> Various leukodystrophies are distinguished from MNGIE disease by clinical features. These include <related-object link-type="booklink" source-id="gene" document-id="mld" document-type="chapter">metachromatic leukodystrophy</related-object>, <related-object link-type="booklink" source-id="gene" document-id="x-ald" document-type="chapter">X-linked adrenoleukodystrophy</related-object>, <related-object link-type="booklink" source-id="gene" document-id="cach" document-type="chapter">childhood ataxia with central nervous system hypomyelination/vanishing white matter disease</related-object>, <italic toggle="yes">GJA12</italic> (connexin 46.6) pathogenic variants, <related-object link-type="booklink" source-id="gene" document-id="pmd" document-type="chapter"><italic toggle="yes">PLP1</italic>-related disorders</related-object>, <related-object link-type="booklink" source-id="gene" document-id="krabbe" document-type="chapter">Krabbe disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="alexander" document-type="chapter">Alexander disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="canavan" document-type="chapter">Canavan disease</related-object>, congenital muscular dystrophy with merosin deficiency (see <related-object link-type="booklink" source-id="gene" document-id="mdef-cmd" document-type="chapter"><italic toggle="yes">LAMA2</italic>-related muscular dystrophy</related-object> and <related-object link-type="booklink" source-id="gene" document-id="cmd-overview" document-type="chapter">Congenital Muscular Dystrophy Overview</related-object>), and <related-object link-type="booklink" source-id="gene" document-id="issd" document-type="chapter">Salla disease</related-object>. See also <related-object link-type="booklink" source-id="gene" document-id="leukodys-ov" document-type="chapter">Leukodystrophy Overview</related-object>.</p>
        <p>Although pathogenic variants in <italic toggle="yes">GJB1</italic>, the gene encoding connexin 32, can be associated with transient white matter defects [<xref ref-type="bibr" rid="mngie.REF.hanemann.2003.605">Hanemann et al 2003</xref>], most affected individuals present with <related-object link-type="booklink" source-id="gene" document-id="cmtx" document-type="chapter">X-linked Charcot-Marie-Tooth disease</related-object> (CMTX).</p>
      </sec>
      <sec id="mngie.Management">
        <title>Management</title>
        <sec id="mngie.Evaluations_at_Initial_Diagnosis">
          <title>Evaluations at Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in a proband with MNGIE (<italic toggle="yes">m</italic>itochondrial <italic toggle="yes">n</italic>euro<italic toggle="yes">g</italic>astro<italic toggle="yes">i</italic>ntestinal <italic toggle="yes">e</italic>ncephalopathy) disease, the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>EMG/NCV</p>
            </list-item>
            <list-item>
              <p>Brain MRI</p>
            </list-item>
            <list-item>
              <p>EKG</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic evaluation</p>
            </list-item>
            <list-item>
              <p>Audiologic evaluation</p>
            </list-item>
            <list-item>
              <p>Assessment of hepatic function, renal function, plasma concentrations of amino acids, and serum concentration of lactate and pyruvate</p>
            </list-item>
            <list-item>
              <p>GI evaluation, which depends on the symptoms and may include abdominal films, abdominal CT, upper GI contrast radiography, esophagogastroduodenoscopy, sigmoidoscopy, liquid phase scintigraphy, and antroduodenal manometry. Radiologic studies may show hypoperistalsis, gastroparesis, dilated duodenum, and diverticulosis. Small bowel manometry shows reduced amplitude of contractions.</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="mngie.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Cooperation among multiple specialties including neurology, clinical genetics, nutrition, gastroenterology, pain management, psychiatry, and physical/occupational therapy helps with timely detection and treatment of the various aspects of multi-organ dysfunction. Once symptoms appear, treatment is primarily supportive.</p>
          <p>Management of GI dysfunction can include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Early attention to swallowing difficulties and airway protection, especially in the most severely affected individuals</p>
            </list-item>
            <list-item>
              <p>Trial of dromperidone for nausea and vomiting</p>
            </list-item>
            <list-item>
              <p>Nutritional support including (when necessary) bolus feedings, gastrostomy tube placement, and total parenteral nutrition</p>
            </list-item>
            <list-item>
              <p>Antibiotic therapy for intestinal bacterial overgrowth, a complication of dysmotility</p>
            </list-item>
            <list-item>
              <p>Celiac plexus block with bupivicaine. This has been successful in reducing pain by interrupting visceral afferent pain sensation and increasing GI motility by inhibiting sympathetic efferent activity to the upper abdominal viscera and much of the small bowel [<xref ref-type="bibr" rid="mngie.REF.teitelbaum.2002.377">Teitelbaum et al 2002</xref>]. Splanchnic nerve block has been used successfully to reduce abdominal pain [<xref ref-type="bibr" rid="mngie.REF.celebi.2006.1073">Celebi et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>Complex medication regimens that include amitriptyline, nortriptyline, and gabapentin for relief of neuropathic symptoms, which are difficult to treat</p>
            </list-item>
            <list-item>
              <p>Specialized schooling arrangements, typically necessary for children and young adults</p>
            </list-item>
            <list-item>
              <p>Physical therapy and occupational therapy to help preserve mobility. Activity as tolerated should be encouraged.</p>
            </list-item>
          </list>
        </sec>
        <sec id="mngie.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>Establishing the correct diagnosis of MNGIE disease may help avoid unnecessary exploratory abdominal surgeries, risks associated with anesthesia, and inappropriate therapies.</p>
          <p>The approximately 20% of individuals with MNGIE disease who have hepatopathy may be at increased risk for worsening hepatic dysfunction caused by medications metabolized by the liver and as a result of total parenteral nutrition. Therefore, medications that are primarily metabolized in the liver should be used with caution.</p>
          <p>Attention to swallowing abnormalities associated with oropharyngeal muscle dysfunction may help decrease the risk for aspiration pneumonia.</p>
          <p>Early attention to diverticulosis can help prevent complications such as ruptured diverticula and fatal peritonitis.</p>
        </sec>
        <sec id="mngie.Surveillance">
          <title>Surveillance</title>
          <p>Breath test to screen for bacterial overgrowth is recommended.</p>
          <p>Surveillance should be individualized based on symptoms and organs affected.</p>
        </sec>
        <sec id="mngie.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Avoid drugs that interfere with mitochondrial function; these include valproate, phenytoin, chloramphenicol, tetracycline, and certain antipsychotic medications [<xref ref-type="bibr" rid="mngie.REF.shoffner.2008">Shoffner 2008</xref>].</p>
          <p>Medications primarily metabolized in the liver should be used with caution [<xref ref-type="bibr" rid="mngie.REF.finkenstedt.2013.41">Finkenstedt et al 2013</xref>].</p>
        </sec>
        <sec id="mngie.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate apparently asymptomatic or minimally symptomatic older and younger sibs of a proband in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures.</p>
          <p>Evaluations can include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Molecular genetic testing if the <italic toggle="yes">TYMP</italic> pathogenic variants in the family are known;</p>
            </list-item>
            <list-item>
              <p>Measurements of thymidine phosphorylase enzyme (See <xref ref-type="sec" rid="mngie.Establishing_the_Diagnosis">Establishing the Diagnosis</xref>, <bold>thymidine phosphorylase enzyme</bold>) activity or plasma concentrations of thymidine and deoxyuridine (see <xref ref-type="sec" rid="mngie.Establishing_the_Diagnosis">Establishing the Diagnosis</xref>, <bold>Plasma concentrations of thymidine and deoxyuridine</bold>) if the <italic toggle="yes">TYMP</italic> pathogenic variants in the family are not known.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="mngie.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="mngie.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Normalization of intracellular thymidine concentrations could reduce the rate of the mtDNA damage, which progressively increases in an individual over time. Possible future treatments include decreasing plasma thymidine concentration by reducing renal reabsorption of thymidine (i.e., blocking the Na+/thymidine transporter), by dialysis, and by enzyme replacement therapy (ERT).</p>
          <p>Approaches to ERT include allogeneic stem cell transplantation (AHSCT) [<xref ref-type="bibr" rid="mngie.REF.hirano.2006.1458">Hirano et al 2006</xref>, <xref ref-type="bibr" rid="mngie.REF.rahman.2007.1872">Rahman &#x00026; Hargreaves 2007</xref>], carrier erythrocyte entrapped thymidine phosphorylase [<xref ref-type="bibr" rid="mngie.REF.moran.2008.686">Moran et al 2008</xref>], and platelet transfusion.</p>
          <list list-type="bullet">
            <list-item>
              <p>AHSCT produced nearly full biochemical correction of the deoxythymidine and deoxyuridine imbalances in blood and clinical improvements after successful engraftment of donor cells; however, high morbidity and mortality (16/25 patients died after AHSCT) precludes general use of this therapy for MNGIE disease [<xref ref-type="bibr" rid="mngie.REF.hirano.2006.1458">Hirano et al 2006</xref>, <xref ref-type="bibr" rid="mngie.REF.halter.2015.2847">Halter et al 2015</xref>, <xref ref-type="bibr" rid="mngie.REF.peedikayil.2015.85">Peedikayil et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>Polymeric enzyme-loaded nanoparticles are being explored for use in MNGIE disease but have not been used in humans [<xref ref-type="bibr" rid="mngie.REF.de_vocht.2009.246">De Vocht et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p>Platelet transfusion produced only transient reductions in blood nucleosides [<xref ref-type="bibr" rid="mngie.REF.lara.2006.1461">Lara et al 2006</xref>].</p>
            </list-item>
          </list>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
        <sec id="mngie.Other">
          <title>Other</title>
          <p>Supplements like coenzyme Q<sub>10</sub>, vitamin K, vitamin C, riboflavin, niacin, and other compounds have no proven efficacy and do not change the natural history of the disease [Shoffner, personal observation].</p>
          <p>Although plasma concentration of thymidine can be reduced by hemodialysis, the plasma concentration becomes elevated again in about three hours [<xref ref-type="bibr" rid="mngie.REF.spinazzola.2002.4128">Spinazzola et al 2002</xref>]. Improvement of symptoms like vomiting and abdominal pain was reported with peritoneal dialysis [<xref ref-type="bibr" rid="mngie.REF.yavuz.2007.435">Yavuz et al 2007</xref>]. No change in blood nucleoside levels was observed.</p>
        </sec>
      </sec>
      <sec id="mngie.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="mngie.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>MNGIE disease is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="mngie.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">TYMP</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Unless an individual with MNGIE disease has offspring with either an affected individual or a carrier, his/her offspring will be obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">TYMP</italic>.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being heterozygous for a <italic toggle="yes">TYMP</italic> pathogenic variant.</p>
        </sec>
        <sec id="mngie.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p><bold>Molecular genetic testing.</bold> Carrier detection for at-risk family members requires prior identification of the <italic toggle="yes">TYMP</italic> pathogenic variants in the family.</p>
          <p><bold>Biochemical genetic testing.</bold> Although they are unaffected, heterozygotes display about 30%-50% residual thymidine phosphorylase enzyme activity which overlaps with control ranges, and thus cannot be used to determine carrier status.</p>
        </sec>
        <sec id="mngie.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="mngie.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="mngie.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">TYMP</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for MNGIE disease are possible.</p>
        </sec>
      </sec>
      <sec id="mngie.Resources">
        <title>Resources</title>
      </sec>
      <sec id="mngie.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="mngie.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>MNGIE (<italic toggle="yes">m</italic>itochondrial <italic toggle="yes">n</italic>euro<italic toggle="yes">g</italic>astro<italic toggle="yes">i</italic>ntestinal <italic toggle="yes">e</italic>ncephalopathy) disease results from the mutagenic effect of thymidine phosphorylase deficiency on mitochondrial DNA (mtDNA). Thymidine phosphorylase deficiency results from pathogenic variants in the nuclear gene <italic toggle="yes">TYMP</italic>. The pathologic consequences of thymidine phosphorylase deficiency are accumulation of qualitative mtDNA defects (deletions and duplications) and quantitative mtDNA defects (depletion) in various tissues over time. Nuclear DNA damage does not appear to be a factor in the pathogenesis of MNGIE disease.</p>
          <p>In MNGIE disease, increases in deoxythymidine and deoxyuridine with relative deficiency of deoxycytidine cause imbalances in mitochondrial deoxynucleotide 5&#x02019;-triphosphate (dNTP) pools with relative excess of deoxythymidine triphosphate (dTTP) and paucity of deoxycytidine triphosphate (dCTP), producing mtDNA instability [<xref ref-type="bibr" rid="mngie.REF.nishigaki.2003.1913">Nishigaki et al 2003</xref>, <xref ref-type="bibr" rid="mngie.REF.l_pez.2009.714">L&#x000f3;pez et al 2009</xref>, <xref ref-type="bibr" rid="mngie.REF.garciadiaz.2014.1337">Garcia-Diaz et al 2014</xref>]. This preferential damage to mtDNA over time appears to be the result of several factors:</p>
          <list list-type="bullet">
            <list-item>
              <p>The mitochondrial dNTP pool is sequestered within the mitochondria.</p>
            </list-item>
            <list-item>
              <p>Mitochondrial DNA is more dependent on thymidine salvage than nuclear DNA, which depends primarily on <italic toggle="yes">de novo</italic> thymidine synthesis.</p>
            </list-item>
            <list-item>
              <p>Mitochondrial DNA has a limited capability to repair damage as compared to nuclear DNA.</p>
            </list-item>
          </list>
          <p>Since mtDNA continues to replicate throughout an individual's life, various tissues throughout the body develop abnormalities over time as a result of progressive oxidative phosphorylation (OXPHOS) impairment. Accumulation of mtDNA pathogenic variants can be observed in fibroblasts and tissues of individuals with MNGIE disease as well in HeLa cells cultured in the presence of increased thymidine [<xref ref-type="bibr" rid="mngie.REF.nishigaki.2003.1913">Nishigaki et al 2003</xref>, <xref ref-type="bibr" rid="mngie.REF.song.2003.43893">Song et al 2003</xref>]. Mitochondrial DNA depletion and mtDNA deletions are present in most individuals with MNGIE disease, but not all [<xref ref-type="bibr" rid="mngie.REF.hirano.1994.721">Hirano et al 1994</xref>, <xref ref-type="bibr" rid="mngie.REF.debouverie.1997.547">Debouverie et al 1997</xref>, <xref ref-type="bibr" rid="mngie.REF.hamano.1997.917">Hamano et al 1997</xref>].</p>
          <p>Thymidine-deficient mice (TP -/-) appear normal and do not show features of MNGIE disease [<xref ref-type="bibr" rid="mngie.REF.haraguchi.2002.5212">Haraguchi et al 2002</xref>]. Since mice can use uridine phosphorylase to clear thymidine, deficiency in both thymidine phosphorylase and uridine phosphorylase are required to affect nucleoside metabolism. Mice that are double mutants for these two enzymes produce increased T<sub>2</sub>-weighted signal on MRI in white matter with partial depletion of mtDNA in brain [<xref ref-type="bibr" rid="mngie.REF.l_pez.2009.714">L&#x000f3;pez et al 2009</xref>]. Oral administration of thymidine and deoxyuridine to the double mutant mice enhances the abnormal phenotype and shortens life span, demonstrating that the nucleosides are toxic to mitochondria [<xref ref-type="bibr" rid="mngie.REF.garciadiaz.2014.1337">Garcia-Diaz et al 2014</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">TYMP</italic> comprises ten exons spanning more than 4.3 kb [<xref ref-type="bibr" rid="mngie.REF.hagiwara.1991.2125">Hagiwara et al 1991</xref>]. See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mngie-Table2.pdf" content-type="local-data">Table 2</inline-supplementary-material> (pdf).</p>
          <p><bold>Pathogenic variants.</bold> The nucleotide positions listed in the genomic DNA are according to <xref ref-type="bibr" rid="mngie.REF.hagiwara.1991.2125">Hagiwara et al [1991]</xref>. No large deletions involving this gene have been described. Note that the pathogenicity of splice-site variants is confirmed by identification of altered splicing in reverse transcriptase (RT) PCR assays.</p>
          <p>See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mngie-Tables3-7.pdf" content-type="local-data">Tables 3-7</inline-supplementary-material> (pdf).</p>
          <p><bold>Normal gene product.</bold> Thymidine phosphorylase is a homodimer that catalyzes the conversion of thymidine to thymine and 2-deoxy-D-ribose 1-phosphate [<xref ref-type="bibr" rid="mngie.REF.brown.1998.1">Brown &#x00026; Bicknell 1998</xref>]. The forward reaction (thymidine to thymine) is important to nucleoside catabolism. Although the reverse reaction is possible (thymidine to thymidine triphosphate), only the forward reaction appears important physiologically. Thymidine phosphorylase is expressed in the GI system, brain, peripheral nerves, autonomic nerves, spleen, bladder, and lungs and is not expressed in muscle, kidney, gallbladder, aorta, or fat.</p>
          <p>Thymidine phosphorylase was originally mistakenly identified as a "growth factor" abundant in platelets; therefore, it was named "platelet-derived endothelial cell growth factor" (PD-ECGF or ECGF1). The misconception that thymidine phosphorylase (TP) is a growth factor is based on [<sup>3</sup>H]-labeled thymidine incorporation assays. Purified "ECGF" was added to cell culture medium 18 hours prior to addition of [<sup>3</sup>H]-thymidine, which was rapidly incorporated by cultured endothelial cells. This result was misinterpreted as stimulation of mitosis. In reality, the addition of TP degraded thymidine in the culture medium, and subsequently the thymidine-starved endothelial cells rapidly incorporated the [<sup>3</sup>H]-thymidine. TP may be angiogenic indirectly because ribose liberated from the degradation of thymidine may stimulate cell division and migration [<xref ref-type="bibr" rid="mngie.REF.brown.1998.1">Brown &#x00026; Bicknell 1998</xref>]. In addition to its function in angiogenesis, it also limits glial cell proliferation.</p>
          <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="mngie.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
        </sec>
      </sec>
      <sec id="mngie.References">
        <title>References</title>
        <sec id="mngie.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="mngie.Literature_Cited.reflist0">
            <ref id="mngie.REF.bedlack.2004.364">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bedlack</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammans</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sparr</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgenlander</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy.</article-title>
                <source>Muscle Nerve</source>
                <volume>29</volume>
                <fpage>364</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14981734</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.brown.1998.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bicknell</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.</article-title>
                <source>Biochem J</source>
                <volume>334</volume>
                <fpage>1</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9693094</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.carodartal.2007.581">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carod-Artal</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrero</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lara</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez-Gallardo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Pesini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montoya</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Cognitive dysfunction and hypogonadotropic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation.</article-title>
                <source>Eur J Neurol</source>
                <volume>14</volume>
                <fpage>581</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17437622</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.celebi.2006.1073">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Celebi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canbay</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uz&#x000fc;mc&#x000fc;gil</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aypar</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Abdominal pain related to mitochondrial neurogastrointestinal encephalomyopathy syndrome may benefit from splanchnic nerve blockade.</article-title>
                <source>Paediatr Anaesth</source>
                <volume>16</volume>
                <fpage>1073</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16972839</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.debouverie.1997.547">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Debouverie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ducrocq</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grignon</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mousson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <comment>[MNGIE syndrome in 2 siblings]</comment>
                <source>Rev Neurol (Paris)</source>
                <volume>153</volume>
                <fpage>547</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">9684018</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.de_vocht.2009.246">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Vocht</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ranquin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willaert</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Ginderachter</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanhaecke</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogiers</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vers&#x000e9;es</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Gelder</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steyaert</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE.</article-title>
                <source>J Control Release</source>
                <volume>137</volume>
                <fpage>246</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">19371766</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.fairbanks.2002.603">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fairbanks</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marinaki</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrey</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammans</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duley</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Deoxyuridine accumulation in urine in thymidine phosphorylase deficiency (MNGIE).</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>25</volume>
                <fpage>603</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12638947</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.finkenstedt.2013.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Finkenstedt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schranz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgi</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ensinger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayr</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janecke</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nachbaur</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>MNGIE syndrome: Liver cirrhosis should be ruled out prior to bone marrow transplantation.</article-title>
                <source>JIMD Reports</source>
                <volume>10</volume>
                <fpage>41</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">23430799</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.garciadiaz.2014.1337">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garcia-Diaz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barca</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mojahed</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutierrez</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pizzorno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanji</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arias-Mendoza</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinzii</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Deoxynucleoside stress exacerbates the phenotype of a mouse model of mitochondrial neurogastrointestinal encephalopathy.</article-title>
                <source>Brain</source>
                <volume>137</volume>
                <fpage>1337</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">24727567</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.garone.2011.3326">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadesse</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy.</article-title>
                <source>Brain</source>
                <volume>134</volume>
                <fpage>3326</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">21933806</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.giordano.2008.1120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sebastiani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Giorgio</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Travaglini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tancredi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossarizza</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>d'Amati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion.</article-title>
                <source>Am J Pathol</source>
                <volume>173</volume>
                <fpage>1120</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18787099</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.giordano.2006.893">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sebastiani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plazzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Travaglini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sale</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tancredi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liguori</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossarizza</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>d'Amati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine.</article-title>
                <source>Gastroenterology</source>
                <volume>130</volume>
                <fpage>893</fpage>
                <lpage>901</lpage>
                <pub-id pub-id-type="pmid">16530527</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.hagiwara.1991.2125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hagiwara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stenman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honda</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahlin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyazono</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heldin</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishikawa</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takaku</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene.</article-title>
                <source>Mol Cell Biol</source>
                <volume>11</volume>
                <fpage>2125</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">2005900</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.halter.2015.2847">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Halter</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michael</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schupbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casali</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orchard</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valcarcel</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rovelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filosto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marotta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pintos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barba</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Accarino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferra</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beguin</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boelens</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fay</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sue</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nachbaur</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobreira</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto Simoes</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammans</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savage</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elhasid</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gratwohl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy.</article-title>
                <source>Brain</source>
                <volume>138</volume>
                <fpage>2847</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">26264513</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.hamano.1997.917">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamano</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohta</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takekawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kouda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinohara</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <comment>[Mitochondrial neurogastrointestinal encephalomyopathy presenting with protein-losing gastroenteropathy and serum copper deficiency: a case report]</comment>
                <source>Rinsho Shinkeigaku</source>
                <volume>37</volume>
                <fpage>917</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">9490904</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.hanemann.2003.605">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanemann</surname>
                    <given-names>CO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergmann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senderek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperfeld</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation.</article-title>
                <source>Arch Neurol</source>
                <volume>60</volume>
                <fpage>605</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12707076</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.haraguchi.2002.5212">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haraguchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsujimoto</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukushima</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higuchi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuribayashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Utsumi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakayama</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashizume</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirato</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hara</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawaguchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyazono</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishikawa</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toyoshima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaname</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komatsu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>ZS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gotanda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tachiwada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sumizawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyadera</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osame</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice.</article-title>
                <source>Mol Cell Biol</source>
                <volume>22</volume>
                <fpage>5212</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">12077348</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.hirano.2006.1458">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casali</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadesse</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uldrick</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Escolar</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hesdorffer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hawks</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martone</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cairo</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanzani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garvin</surname>
                    <given-names>JH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Savage</surname>
                    <given-names>DG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE.</article-title>
                <source>Neurology</source>
                <volume>67</volume>
                <fpage>1458</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">16971696</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.hirano.2004.8">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishigaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes.</article-title>
                <source>Neurologist</source>
                <volume>10</volume>
                <fpage>8</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">14720311</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.hirano.1994.721">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvestri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blake</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lombes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hays</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovelace</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertorini</surname>
                    <given-names>TE</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder.</article-title>
                <source>Neurology</source>
                <volume>44</volume>
                <fpage>721</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8164833</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.kalkan.2012.377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kalkan</surname>
                    <given-names>IH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tayfur</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oztas</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beyazit</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yildiz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tunc</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>A novel finding in MNGIE (mitochondrial neurogastrointestinal encephalomyopathy): hypergonadotropic hypogonadism.</article-title>
                <source>Hormones</source>
                <volume>11</volume>
                <fpage>377</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22908072</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.kaukonen.2000.782">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaukonen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juselius</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiranti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kyttala</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keranen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Role of adenine nucleotide translocator 1 in mtDNA maintenance.</article-title>
                <source>Science</source>
                <volume>289</volume>
                <fpage>782</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10926541</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.kornblum.2013.214">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kornblum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholls</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haack</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peeva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danhauser</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zsurka</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rorbach</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iuso</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieland</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sciacco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronchi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinzii</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvo</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mootha</surname>
                    <given-names>VK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klopstock</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meitinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minczuk</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunz</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prokisch</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease.</article-title>
                <source>Nat Genet.</source>
                <volume>45</volume>
                <fpage>214</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23313956</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.lara.2006.1461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lara</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madoz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massuet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreu</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anikster</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Infusion of platelets transiently reduces nucleoside overload in MNGIE.</article-title>
                <source>Neurology</source>
                <volume>67</volume>
                <fpage>1461</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16971699</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.l_pez.2009.714">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L&#x000f3;pez</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akman</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Cazorla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorado</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadesse</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pizzorno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shungu</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanji</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase deficient mice.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>18</volume>
                <fpage>714</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">19028666</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.mandel.2001.337">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szargel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labay</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elpeleg</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saada</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shalata</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anbinder</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkowitz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eriksson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA.</article-title>
                <source>Nat Genet</source>
                <volume>29</volume>
                <fpage>337</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">11687800</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.mart_.2003.14">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mart&#x000ed;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishigaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>303</volume>
                <fpage>14</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12646159</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.mart_.2004.120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mart&#x000ed;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinazzola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadesse</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishigaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays.</article-title>
                <source>Clin Chem</source>
                <volume>50</volume>
                <fpage>120</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">14633909</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.mart_.2005.649">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mart&#x000ed;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verschuuren</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadesse</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Kuilenburg</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Gennip</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poorthuis</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Late-onset MNGIE due to partial loss of thymidine phosphorylase activity.</article-title>
                <source>Ann Neurol.</source>
                <volume>58</volume>
                <fpage>649</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">16178026</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.massa.2009.837">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Massa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tessa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margollicci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Micheli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romigi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tozzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terracciano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piemonte</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernardi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Late-onset MNGIE without peripheral neuropathy due to incomplete loss of thymidine phosphorylase activity.</article-title>
                <source>Neuromuscular disorders</source>
                <volume>19</volume>
                <fpage>837</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">19853446</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.moran.2008.686">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moran</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bain</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muqit</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bax</surname>
                    <given-names>BE</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE.</article-title>
                <source>Neurology</source>
                <volume>71</volume>
                <fpage>686</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18725595</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.nishigaki.2003.1913">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nishigaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copeland</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency.</article-title>
                <source>J Clin Invest</source>
                <volume>111</volume>
                <fpage>1913</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">12813027</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.nishino.1999.689">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinazzola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder.</article-title>
                <source>Science</source>
                <volume>283</volume>
                <fpage>689</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">9924029</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.nishino.2000.792">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinazzola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadimitriou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammans</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steiner</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connolly</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verloes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guimaraes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maillard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamano</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donati</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semrad</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreu</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadjigeorgiou</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vu</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadesse</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nygaard</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowland</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations.</article-title>
                <source>Ann Neurol</source>
                <volume>47</volume>
                <fpage>792</fpage>
                <lpage>800</lpage>
                <pub-id pub-id-type="pmid">10852545</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.peedikayil.2015.85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peedikayil</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kagevi</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abufarhaneh</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alsayed</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alzahrani</surname>
                    <given-names>HA</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial neurogastrointestinal encephalomyopathy treated with stem cell transplantation: a case report and review of literature.</article-title>
                <source>Hematol Oncol Stem Cell Ther.</source>
                <year>2015</year>
                <volume>8</volume>
                <fpage>85</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">25585305</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.perezatayde.1998.1141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perez-Atayde</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teitelbaum</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anthony</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fadic</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalsner</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivkin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johns</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>GF</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Mitochondrial neurogastrointestinal encephalomyopathy: diagnosis by rectal biopsy.</article-title>
                <source>Am J Surg Pathol</source>
                <volume>22</volume>
                <fpage>1141</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9737248</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.rahman.2007.1872">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hargreaves</surname>
                    <given-names>IP</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE.</article-title>
                <source>Neurology</source>
                <volume>68</volume>
                <fpage>1872</fpage>
                <pub-id pub-id-type="pmid">17515557</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.saada.2001.342">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saada</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaag</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nevo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eriksson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elpeleg</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy.</article-title>
                <source>Nat Genet</source>
                <volume>29</volume>
                <fpage>342</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11687801</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.said.2005.655">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Said</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacroix</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plante-Bordeneuve</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messing</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slama</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crenn</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nivelon-Chevallier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bedenne</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soichot</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manceau</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigaud</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guiochon-Mantel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matuchansky</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopathy (MNGIE) in four patients including two with a Charcot-Marie-Tooth presentation.</article-title>
                <source>J Neurol</source>
                <volume>252</volume>
                <fpage>655</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">15742109</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.schon.2012.878">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Human mitochondrial DNA: roles of inherited and somatic mutations.</article-title>
                <source>Nat Rev Genet.</source>
                <year>2012</year>
                <volume>13</volume>
                <fpage>878</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">23154810</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.shoffner.2008">
              <mixed-citation publication-type="book">Shoffner JM. Mitochondrial diseases. MedLink Neurology. San Diego, CA: S Gilman, MedLink Corporation. 2008.</mixed-citation>
            </ref>
            <ref id="mngie.REF.spinazzola.2006.570">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spinazzola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viscomi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez-Vizarra</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Adamo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsano</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donnini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiher</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strisciuglio</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarzi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rotig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasparini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrero</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mootha</surname>
                    <given-names>VK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiranti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion.</article-title>
                <source>Nat Genet</source>
                <volume>38</volume>
                <fpage>570</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16582910</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.song.2003.43893">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheeler</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathews</surname>
                    <given-names>CK</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA.</article-title>
                <source>J Biol Chem</source>
                <volume>278</volume>
                <fpage>43893</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">13679382</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.spelbrink.2001.223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spelbrink</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>FY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiranti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikali</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>QP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tariq</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wanrooij</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrido</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morandi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santoro</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toscano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fabrizi</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Croxen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobs</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsson</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria.</article-title>
                <source>Nat Genet</source>
                <volume>28</volume>
                <fpage>223</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">11431692</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.spinazzola.2002.4128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spinazzola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreu</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadesse</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pela</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zammarchi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donati</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliver</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Altered thymidine metabolism due to defects of thymidine phosphorylase.</article-title>
                <source>J Biol Chem</source>
                <volume>277</volume>
                <fpage>4128</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">11733540</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.szigeti.2004.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Szigeti</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perng</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saifi</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eldin</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adesina</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cass</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scaglia</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>125</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14757860</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.teitelbaum.2002.377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Teitelbaum</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berde</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nurko</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buonomo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez-Atayde</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>VL</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Diagnosis and management of MNGIE syndrome in children: case report and review of the literature.</article-title>
                <source>J Pediatr Gastroenterol Nutr</source>
                <volume>35</volume>
                <fpage>377</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">12352533</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.valentino.2007.3410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadesse</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manes</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyzak</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).</article-title>
                <source>FEBS Lett</source>
                <volume>581</volume>
                <fpage>3410</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17612528</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.van_goethem.2001.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Goethem</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dermaut</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lofgren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions.</article-title>
                <source>Nat Genet</source>
                <volume>28</volume>
                <fpage>211</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">11431686</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.vissing.2002.926">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravn</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danielsen</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wibrand</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Multiple mtDNA deletions with features of MNGIE.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>926</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12297582</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.yavuz.2007.435">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yavuz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elmaci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis.</article-title>
                <source>Arch Neurol</source>
                <volume>64</volume>
                <fpage>435</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17353390</pub-id>
              </element-citation>
            </ref>
            <ref id="mngie.REF.zimmer.2009.627">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zimmer</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feiden</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reith</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raedle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lammert</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeuzem</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menges</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Absence of the interstitial cell of Cajal network in mitochondrial neurogastrointestinal encephalomyopathy.</article-title>
                <source>Neurogastroenterol Motil</source>
                <volume>21</volume>
                <fpage>627</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">19368660</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="mngie.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="mngie.Author_History">
          <title>Author History</title>
          <p>Michio Hirano, MD (2016-present)John M Shoffner, MD; Georgia State University (2005-2016)</p>
        </sec>
        <sec id="mngie.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>14 January 2016 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>11 May 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>22 April 2005 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>16 September 2004 (jms) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
